nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLC22A6—Methazolamide—glaucoma	0.0857	0.556	CbGbCtD
Acetylcysteine—SLC22A6—Acetazolamide—glaucoma	0.0685	0.444	CbGbCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00129	0.00244	CcSEcCtD
Acetylcysteine—Erythema—Travoprost—glaucoma	0.00128	0.00243	CcSEcCtD
Acetylcysteine—Oedema—Apraclonidine—glaucoma	0.00128	0.00243	CcSEcCtD
Acetylcysteine—Hypersensitivity—Levobunolol—glaucoma	0.00127	0.00241	CcSEcCtD
Acetylcysteine—Pruritus—Diclofenamide—glaucoma	0.00127	0.00241	CcSEcCtD
Acetylcysteine—Eye pain—Timolol—glaucoma	0.00127	0.00241	CcSEcCtD
Acetylcysteine—Erythema—Brinzolamide—glaucoma	0.00127	0.0024	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Betaxolol—glaucoma	0.00126	0.00238	CcSEcCtD
Acetylcysteine—Rash—Metipranolol—glaucoma	0.00125	0.00236	CcSEcCtD
Acetylcysteine—Skin disorder—Apraclonidine—glaucoma	0.00125	0.00236	CcSEcCtD
Acetylcysteine—Dermatitis—Metipranolol—glaucoma	0.00124	0.00235	CcSEcCtD
Acetylcysteine—Drowsiness—Clonidine—glaucoma	0.00124	0.00235	CcSEcCtD
Acetylcysteine—Pruritus—Levobunolol—glaucoma	0.00122	0.00231	CcSEcCtD
Acetylcysteine—Asthma—Betaxolol—glaucoma	0.00121	0.0023	CcSEcCtD
Acetylcysteine—Dizziness—Carteolol—glaucoma	0.00121	0.00229	CcSEcCtD
Acetylcysteine—Syncope—Brimonidine—glaucoma	0.00121	0.00229	CcSEcCtD
Acetylcysteine—Skin disorder—Bimatoprost—glaucoma	0.00121	0.00228	CcSEcCtD
Acetylcysteine—Bronchospasm—Betaxolol—glaucoma	0.00119	0.00226	CcSEcCtD
Acetylcysteine—Sweating—Clonidine—glaucoma	0.00119	0.00226	CcSEcCtD
Acetylcysteine—Dizziness—Diclofenamide—glaucoma	0.00119	0.00225	CcSEcCtD
Acetylcysteine—Loss of consciousness—Brimonidine—glaucoma	0.00119	0.00224	CcSEcCtD
Acetylcysteine—Angioedema—Dorzolamide—glaucoma	0.00118	0.00223	CcSEcCtD
Acetylcysteine—Cough—Brimonidine—glaucoma	0.00118	0.00223	CcSEcCtD
Acetylcysteine—Nausea—Metipranolol—glaucoma	0.00117	0.00222	CcSEcCtD
Acetylcysteine—Dizziness—Carbachol—glaucoma	0.00116	0.0022	CcSEcCtD
Acetylcysteine—Syncope—Dorzolamide—glaucoma	0.00115	0.00219	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Acetazolamide—glaucoma	0.00115	0.00217	CcSEcCtD
Acetylcysteine—Vomiting—Diclofenamide—glaucoma	0.00114	0.00216	CcSEcCtD
Acetylcysteine—Dizziness—Levobunolol—glaucoma	0.00114	0.00216	CcSEcCtD
Acetylcysteine—Dyspnoea—Apraclonidine—glaucoma	0.00114	0.00216	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00114	0.00216	CcSEcCtD
Acetylcysteine—Somnolence—Apraclonidine—glaucoma	0.00114	0.00216	CcSEcCtD
Acetylcysteine—Pruritus—Latanoprost—glaucoma	0.00113	0.00215	CcSEcCtD
Acetylcysteine—Rash—Diclofenamide—glaucoma	0.00113	0.00215	CcSEcCtD
Acetylcysteine—Loss of consciousness—Dorzolamide—glaucoma	0.00113	0.00214	CcSEcCtD
Acetylcysteine—Shock—Acetazolamide—glaucoma	0.00113	0.00213	CcSEcCtD
Acetylcysteine—Cough—Dorzolamide—glaucoma	0.00112	0.00213	CcSEcCtD
Acetylcysteine—Cough—Travoprost—glaucoma	0.00112	0.00212	CcSEcCtD
Acetylcysteine—Vomiting—Carbachol—glaucoma	0.00112	0.00211	CcSEcCtD
Acetylcysteine—Dyspnoea—Bimatoprost—glaucoma	0.00111	0.0021	CcSEcCtD
Acetylcysteine—Rash—Carbachol—glaucoma	0.00111	0.00209	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00111	0.00209	CcSEcCtD
Acetylcysteine—Dermatitis—Carbachol—glaucoma	0.00111	0.00209	CcSEcCtD
Acetylcysteine—Somnolence—Bimatoprost—glaucoma	0.0011	0.00209	CcSEcCtD
Acetylcysteine—Cough—Brinzolamide—glaucoma	0.0011	0.00209	CcSEcCtD
Acetylcysteine—Oedema—Brimonidine—glaucoma	0.0011	0.00208	CcSEcCtD
Acetylcysteine—Dyspepsia—Bimatoprost—glaucoma	0.00109	0.00207	CcSEcCtD
Acetylcysteine—Syncope—Pilocarpine—glaucoma	0.00109	0.00206	CcSEcCtD
Acetylcysteine—Nausea—Carteolol—glaucoma	0.00109	0.00206	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00108	0.00205	CcSEcCtD
Acetylcysteine—Shock—Brimonidine—glaucoma	0.00108	0.00205	CcSEcCtD
Acetylcysteine—Tachycardia—Brimonidine—glaucoma	0.00107	0.00203	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00107	0.00203	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00107	0.00203	CcSEcCtD
Acetylcysteine—Loss of consciousness—Pilocarpine—glaucoma	0.00107	0.00202	CcSEcCtD
Acetylcysteine—Skin disorder—Brimonidine—glaucoma	0.00107	0.00202	CcSEcCtD
Acetylcysteine—Nausea—Diclofenamide—glaucoma	0.00107	0.00202	CcSEcCtD
Acetylcysteine—Cough—Pilocarpine—glaucoma	0.00106	0.00201	CcSEcCtD
Acetylcysteine—Dizziness—Latanoprost—glaucoma	0.00106	0.00201	CcSEcCtD
Acetylcysteine—Stomatitis—Betaxolol—glaucoma	0.00106	0.002	CcSEcCtD
Acetylcysteine—Vomiting—Methazolamide—glaucoma	0.00105	0.00199	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Dorzolamide—glaucoma	0.00105	0.00199	CcSEcCtD
Acetylcysteine—Oedema—Dorzolamide—glaucoma	0.00105	0.00199	CcSEcCtD
Acetylcysteine—Oedema—Travoprost—glaucoma	0.00105	0.00198	CcSEcCtD
Acetylcysteine—Rash—Methazolamide—glaucoma	0.00104	0.00198	CcSEcCtD
Acetylcysteine—Dermatitis—Methazolamide—glaucoma	0.00104	0.00197	CcSEcCtD
Acetylcysteine—Nausea—Carbachol—glaucoma	0.00104	0.00197	CcSEcCtD
Acetylcysteine—Sweating—Betaxolol—glaucoma	0.00104	0.00196	CcSEcCtD
Acetylcysteine—Cardiac disorder—Clonidine—glaucoma	0.00104	0.00196	CcSEcCtD
Acetylcysteine—Shock—Dorzolamide—glaucoma	0.00103	0.00196	CcSEcCtD
Acetylcysteine—Hypotension—Brimonidine—glaucoma	0.00103	0.00195	CcSEcCtD
Acetylcysteine—Nausea—Levobunolol—glaucoma	0.00103	0.00194	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Timolol—glaucoma	0.00103	0.00194	CcSEcCtD
Acetylcysteine—Tachycardia—Travoprost—glaucoma	0.00102	0.00193	CcSEcCtD
Acetylcysteine—Somnolence—Acetazolamide—glaucoma	0.00102	0.00193	CcSEcCtD
Acetylcysteine—Skin disorder—Travoprost—glaucoma	0.00102	0.00192	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Dorzolamide—glaucoma	0.00102	0.00192	CcSEcCtD
Acetylcysteine—Angiopathy—Clonidine—glaucoma	0.00101	0.00192	CcSEcCtD
Acetylcysteine—Rash—Latanoprost—glaucoma	0.00101	0.00191	CcSEcCtD
Acetylcysteine—Dermatitis—Latanoprost—glaucoma	0.00101	0.00191	CcSEcCtD
Acetylcysteine—Dyspepsia—Acetazolamide—glaucoma	0.00101	0.00191	CcSEcCtD
Acetylcysteine—Tachycardia—Brinzolamide—glaucoma	0.00101	0.00191	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Clonidine—glaucoma	0.00101	0.0019	CcSEcCtD
Acetylcysteine—Skin disorder—Brinzolamide—glaucoma	0.001	0.0019	CcSEcCtD
Acetylcysteine—Oedema—Pilocarpine—glaucoma	0.000993	0.00188	CcSEcCtD
Acetylcysteine—Asthma—Timolol—glaucoma	0.000992	0.00188	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00099	0.00187	CcSEcCtD
Acetylcysteine—Nausea—Methazolamide—glaucoma	0.000984	0.00186	CcSEcCtD
Acetylcysteine—Hypotension—Dorzolamide—glaucoma	0.000982	0.00186	CcSEcCtD
Acetylcysteine—Dyspnoea—Brimonidine—glaucoma	0.000981	0.00186	CcSEcCtD
Acetylcysteine—Somnolence—Brimonidine—glaucoma	0.000978	0.00185	CcSEcCtD
Acetylcysteine—Hypotension—Travoprost—glaucoma	0.000978	0.00185	CcSEcCtD
Acetylcysteine—Shock—Pilocarpine—glaucoma	0.000977	0.00185	CcSEcCtD
Acetylcysteine—Bronchospasm—Timolol—glaucoma	0.000976	0.00185	CcSEcCtD
Acetylcysteine—Erythema—Clonidine—glaucoma	0.000972	0.00184	CcSEcCtD
Acetylcysteine—Tachycardia—Pilocarpine—glaucoma	0.000969	0.00183	CcSEcCtD
Acetylcysteine—Dyspepsia—Brimonidine—glaucoma	0.000969	0.00183	CcSEcCtD
Acetylcysteine—Hypotension—Brinzolamide—glaucoma	0.000965	0.00183	CcSEcCtD
Acetylcysteine—Pharyngitis—Betaxolol—glaucoma	0.000965	0.00183	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Pilocarpine—glaucoma	0.00096	0.00182	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Brimonidine—glaucoma	0.00095	0.0018	CcSEcCtD
Acetylcysteine—Hypersensitivity—Apraclonidine—glaucoma	0.000944	0.00179	CcSEcCtD
Acetylcysteine—Dyspnoea—Dorzolamide—glaucoma	0.000937	0.00177	CcSEcCtD
Acetylcysteine—Somnolence—Dorzolamide—glaucoma	0.000934	0.00177	CcSEcCtD
Acetylcysteine—Dyspnoea—Travoprost—glaucoma	0.000933	0.00177	CcSEcCtD
Acetylcysteine—Hypotension—Pilocarpine—glaucoma	0.000928	0.00176	CcSEcCtD
Acetylcysteine—Dyspepsia—Dorzolamide—glaucoma	0.000925	0.00175	CcSEcCtD
Acetylcysteine—Dyspnoea—Brinzolamide—glaucoma	0.000921	0.00174	CcSEcCtD
Acetylcysteine—Dyspepsia—Travoprost—glaucoma	0.000921	0.00174	CcSEcCtD
Acetylcysteine—Somnolence—Brinzolamide—glaucoma	0.000919	0.00174	CcSEcCtD
Acetylcysteine—Urticaria—Acetazolamide—glaucoma	0.000911	0.00172	CcSEcCtD
Acetylcysteine—Dyspepsia—Brinzolamide—glaucoma	0.00091	0.00172	CcSEcCtD
Acetylcysteine—Pruritus—Apraclonidine—glaucoma	0.000907	0.00172	CcSEcCtD
Acetylcysteine—Body temperature increased—Acetazolamide—glaucoma	0.000906	0.00172	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Travoprost—glaucoma	0.000903	0.00171	CcSEcCtD
Acetylcysteine—Cardiac disorder—Betaxolol—glaucoma	0.000902	0.00171	CcSEcCtD
Acetylcysteine—Flushing—Betaxolol—glaucoma	0.000902	0.00171	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000892	0.00169	CcSEcCtD
Acetylcysteine—Angioedema—Clonidine—glaucoma	0.000888	0.00168	CcSEcCtD
Acetylcysteine—Dyspnoea—Pilocarpine—glaucoma	0.000885	0.00168	CcSEcCtD
Acetylcysteine—Somnolence—Pilocarpine—glaucoma	0.000883	0.00167	CcSEcCtD
Acetylcysteine—Angiopathy—Betaxolol—glaucoma	0.000882	0.00167	CcSEcCtD
Acetylcysteine—Pruritus—Bimatoprost—glaucoma	0.000879	0.00166	CcSEcCtD
Acetylcysteine—Immune system disorder—Betaxolol—glaucoma	0.000878	0.00166	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Betaxolol—glaucoma	0.000876	0.00166	CcSEcCtD
Acetylcysteine—Dyspepsia—Pilocarpine—glaucoma	0.000874	0.00165	CcSEcCtD
Acetylcysteine—Syncope—Clonidine—glaucoma	0.000871	0.00165	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000857	0.00162	CcSEcCtD
Acetylcysteine—Loss of consciousness—Clonidine—glaucoma	0.000854	0.00162	CcSEcCtD
Acetylcysteine—Cough—Clonidine—glaucoma	0.000848	0.0016	CcSEcCtD
Acetylcysteine—Sweating—Timolol—glaucoma	0.000848	0.0016	CcSEcCtD
Acetylcysteine—Dizziness—Apraclonidine—glaucoma	0.000848	0.0016	CcSEcCtD
Acetylcysteine—Erythema—Betaxolol—glaucoma	0.000846	0.0016	CcSEcCtD
Acetylcysteine—Urticaria—Dorzolamide—glaucoma	0.000835	0.00158	CcSEcCtD
Acetylcysteine—Body temperature increased—Dorzolamide—glaucoma	0.000831	0.00157	CcSEcCtD
Acetylcysteine—Dizziness—Bimatoprost—glaucoma	0.000822	0.00156	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000822	0.00155	CcSEcCtD
Acetylcysteine—Urticaria—Brinzolamide—glaucoma	0.000821	0.00155	CcSEcCtD
Acetylcysteine—Vomiting—Apraclonidine—glaucoma	0.000815	0.00154	CcSEcCtD
Acetylcysteine—Hypersensitivity—Brimonidine—glaucoma	0.000811	0.00153	CcSEcCtD
Acetylcysteine—Dermatitis—Apraclonidine—glaucoma	0.000807	0.00153	CcSEcCtD
Acetylcysteine—Oedema—Clonidine—glaucoma	0.000793	0.0015	CcSEcCtD
Acetylcysteine—Body temperature increased—Pilocarpine—glaucoma	0.000785	0.00149	CcSEcCtD
Acetylcysteine—Rash—Bimatoprost—glaucoma	0.000784	0.00148	CcSEcCtD
Acetylcysteine—Dermatitis—Bimatoprost—glaucoma	0.000783	0.00148	CcSEcCtD
Acetylcysteine—Shock—Clonidine—glaucoma	0.00078	0.00148	CcSEcCtD
Acetylcysteine—Pruritus—Brimonidine—glaucoma	0.000779	0.00147	CcSEcCtD
Acetylcysteine—Hypersensitivity—Dorzolamide—glaucoma	0.000774	0.00147	CcSEcCtD
Acetylcysteine—Tachycardia—Clonidine—glaucoma	0.000774	0.00146	CcSEcCtD
Acetylcysteine—Hypersensitivity—Travoprost—glaucoma	0.000771	0.00146	CcSEcCtD
Acetylcysteine—Skin disorder—Clonidine—glaucoma	0.00077	0.00146	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Clonidine—glaucoma	0.000767	0.00145	CcSEcCtD
Acetylcysteine—Nausea—Apraclonidine—glaucoma	0.000761	0.00144	CcSEcCtD
Acetylcysteine—Hypersensitivity—Brinzolamide—glaucoma	0.000761	0.00144	CcSEcCtD
Acetylcysteine—Syncope—Betaxolol—glaucoma	0.000759	0.00144	CcSEcCtD
Acetylcysteine—Dizziness—Acetazolamide—glaucoma	0.000758	0.00143	CcSEcCtD
Acetylcysteine—Pruritus—Dorzolamide—glaucoma	0.000744	0.00141	CcSEcCtD
Acetylcysteine—Loss of consciousness—Betaxolol—glaucoma	0.000744	0.00141	CcSEcCtD
Acetylcysteine—Hypotension—Clonidine—glaucoma	0.000741	0.0014	CcSEcCtD
Acetylcysteine—Pruritus—Travoprost—glaucoma	0.00074	0.0014	CcSEcCtD
Acetylcysteine—Cough—Betaxolol—glaucoma	0.000738	0.0014	CcSEcCtD
Acetylcysteine—Nausea—Bimatoprost—glaucoma	0.000738	0.0014	CcSEcCtD
Acetylcysteine—Cardiac disorder—Timolol—glaucoma	0.000737	0.00139	CcSEcCtD
Acetylcysteine—Hypersensitivity—Pilocarpine—glaucoma	0.000732	0.00138	CcSEcCtD
Acetylcysteine—Pruritus—Brinzolamide—glaucoma	0.000731	0.00138	CcSEcCtD
Acetylcysteine—Vomiting—Acetazolamide—glaucoma	0.000729	0.00138	CcSEcCtD
Acetylcysteine—Dizziness—Brimonidine—glaucoma	0.000728	0.00138	CcSEcCtD
Acetylcysteine—Angiopathy—Timolol—glaucoma	0.00072	0.00136	CcSEcCtD
Acetylcysteine—Immune system disorder—Timolol—glaucoma	0.000717	0.00136	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Timolol—glaucoma	0.000716	0.00135	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000715	0.00135	CcSEcCtD
Acetylcysteine—Dyspnoea—Clonidine—glaucoma	0.000707	0.00134	CcSEcCtD
Acetylcysteine—Somnolence—Clonidine—glaucoma	0.000705	0.00133	CcSEcCtD
Acetylcysteine—Pruritus—Pilocarpine—glaucoma	0.000703	0.00133	CcSEcCtD
Acetylcysteine—Dizziness—Dorzolamide—glaucoma	0.000695	0.00132	CcSEcCtD
Acetylcysteine—Rash—Brimonidine—glaucoma	0.000694	0.00131	CcSEcCtD
Acetylcysteine—Dermatitis—Brimonidine—glaucoma	0.000693	0.00131	CcSEcCtD
Acetylcysteine—Dizziness—Travoprost—glaucoma	0.000692	0.00131	CcSEcCtD
Acetylcysteine—Erythema—Timolol—glaucoma	0.000691	0.00131	CcSEcCtD
Acetylcysteine—Oedema—Betaxolol—glaucoma	0.00069	0.00131	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Clonidine—glaucoma	0.000685	0.0013	CcSEcCtD
Acetylcysteine—Dizziness—Brinzolamide—glaucoma	0.000683	0.00129	CcSEcCtD
Acetylcysteine—Nausea—Acetazolamide—glaucoma	0.000681	0.00129	CcSEcCtD
Acetylcysteine—Shock—Betaxolol—glaucoma	0.000679	0.00129	CcSEcCtD
Acetylcysteine—Tachycardia—Betaxolol—glaucoma	0.000674	0.00128	CcSEcCtD
Acetylcysteine—Skin disorder—Betaxolol—glaucoma	0.000671	0.00127	CcSEcCtD
Acetylcysteine—Vomiting—Dorzolamide—glaucoma	0.000668	0.00126	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Betaxolol—glaucoma	0.000667	0.00126	CcSEcCtD
Acetylcysteine—Rash—Dorzolamide—glaucoma	0.000663	0.00125	CcSEcCtD
Acetylcysteine—Dermatitis—Dorzolamide—glaucoma	0.000662	0.00125	CcSEcCtD
Acetylcysteine—Rash—Travoprost—glaucoma	0.00066	0.00125	CcSEcCtD
Acetylcysteine—Dermatitis—Travoprost—glaucoma	0.000659	0.00125	CcSEcCtD
Acetylcysteine—Vomiting—Brinzolamide—glaucoma	0.000657	0.00124	CcSEcCtD
Acetylcysteine—Dizziness—Pilocarpine—glaucoma	0.000657	0.00124	CcSEcCtD
Acetylcysteine—Nausea—Brimonidine—glaucoma	0.000654	0.00124	CcSEcCtD
Acetylcysteine—Rash—Brinzolamide—glaucoma	0.000651	0.00123	CcSEcCtD
Acetylcysteine—Dermatitis—Brinzolamide—glaucoma	0.000651	0.00123	CcSEcCtD
Acetylcysteine—Hypotension—Betaxolol—glaucoma	0.000645	0.00122	CcSEcCtD
Acetylcysteine—Angioedema—Timolol—glaucoma	0.000631	0.00119	CcSEcCtD
Acetylcysteine—Vomiting—Pilocarpine—glaucoma	0.000631	0.00119	CcSEcCtD
Acetylcysteine—Urticaria—Clonidine—glaucoma	0.00063	0.00119	CcSEcCtD
Acetylcysteine—Body temperature increased—Clonidine—glaucoma	0.000627	0.00119	CcSEcCtD
Acetylcysteine—Rash—Pilocarpine—glaucoma	0.000626	0.00118	CcSEcCtD
Acetylcysteine—Dermatitis—Pilocarpine—glaucoma	0.000626	0.00118	CcSEcCtD
Acetylcysteine—Nausea—Dorzolamide—glaucoma	0.000624	0.00118	CcSEcCtD
Acetylcysteine—Nausea—Travoprost—glaucoma	0.000622	0.00118	CcSEcCtD
Acetylcysteine—Syncope—Timolol—glaucoma	0.00062	0.00117	CcSEcCtD
Acetylcysteine—Dyspnoea—Betaxolol—glaucoma	0.000616	0.00116	CcSEcCtD
Acetylcysteine—Nausea—Brinzolamide—glaucoma	0.000614	0.00116	CcSEcCtD
Acetylcysteine—Dyspepsia—Betaxolol—glaucoma	0.000608	0.00115	CcSEcCtD
Acetylcysteine—Loss of consciousness—Timolol—glaucoma	0.000607	0.00115	CcSEcCtD
Acetylcysteine—Cough—Timolol—glaucoma	0.000603	0.00114	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000596	0.00113	CcSEcCtD
Acetylcysteine—Nausea—Pilocarpine—glaucoma	0.00059	0.00112	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000584	0.00111	CcSEcCtD
Acetylcysteine—Hypersensitivity—Clonidine—glaucoma	0.000584	0.00111	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Timolol—glaucoma	0.000564	0.00107	CcSEcCtD
Acetylcysteine—Oedema—Timolol—glaucoma	0.000564	0.00107	CcSEcCtD
Acetylcysteine—Pruritus—Clonidine—glaucoma	0.000561	0.00106	CcSEcCtD
Acetylcysteine—Shock—Timolol—glaucoma	0.000555	0.00105	CcSEcCtD
Acetylcysteine—Urticaria—Betaxolol—glaucoma	0.000548	0.00104	CcSEcCtD
Acetylcysteine—Skin disorder—Timolol—glaucoma	0.000548	0.00104	CcSEcCtD
Acetylcysteine—Body temperature increased—Betaxolol—glaucoma	0.000546	0.00103	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Timolol—glaucoma	0.000545	0.00103	CcSEcCtD
Acetylcysteine—Hypotension—Timolol—glaucoma	0.000527	0.000997	CcSEcCtD
Acetylcysteine—Dizziness—Clonidine—glaucoma	0.000524	0.000992	CcSEcCtD
Acetylcysteine—Hypersensitivity—Betaxolol—glaucoma	0.000509	0.000963	CcSEcCtD
Acetylcysteine—Vomiting—Clonidine—glaucoma	0.000504	0.000954	CcSEcCtD
Acetylcysteine—Dyspnoea—Timolol—glaucoma	0.000503	0.000951	CcSEcCtD
Acetylcysteine—Somnolence—Timolol—glaucoma	0.000501	0.000949	CcSEcCtD
Acetylcysteine—Rash—Clonidine—glaucoma	0.0005	0.000946	CcSEcCtD
Acetylcysteine—Dermatitis—Clonidine—glaucoma	0.0005	0.000945	CcSEcCtD
Acetylcysteine—Dyspepsia—Timolol—glaucoma	0.000496	0.000939	CcSEcCtD
Acetylcysteine—Pruritus—Betaxolol—glaucoma	0.000488	0.000924	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Timolol—glaucoma	0.000487	0.000921	CcSEcCtD
Acetylcysteine—Nausea—Clonidine—glaucoma	0.000471	0.000891	CcSEcCtD
Acetylcysteine—Dizziness—Betaxolol—glaucoma	0.000457	0.000864	CcSEcCtD
Acetylcysteine—Urticaria—Timolol—glaucoma	0.000448	0.000848	CcSEcCtD
Acetylcysteine—Body temperature increased—Timolol—glaucoma	0.000446	0.000844	CcSEcCtD
Acetylcysteine—Vomiting—Betaxolol—glaucoma	0.000439	0.000831	CcSEcCtD
Acetylcysteine—Rash—Betaxolol—glaucoma	0.000435	0.000824	CcSEcCtD
Acetylcysteine—Dermatitis—Betaxolol—glaucoma	0.000435	0.000823	CcSEcCtD
Acetylcysteine—Hypersensitivity—Timolol—glaucoma	0.000416	0.000786	CcSEcCtD
Acetylcysteine—Nausea—Betaxolol—glaucoma	0.00041	0.000776	CcSEcCtD
Acetylcysteine—Pruritus—Timolol—glaucoma	0.000399	0.000755	CcSEcCtD
Acetylcysteine—Dizziness—Timolol—glaucoma	0.000373	0.000706	CcSEcCtD
Acetylcysteine—Vomiting—Timolol—glaucoma	0.000359	0.000679	CcSEcCtD
Acetylcysteine—Rash—Timolol—glaucoma	0.000356	0.000673	CcSEcCtD
Acetylcysteine—Dermatitis—Timolol—glaucoma	0.000355	0.000672	CcSEcCtD
Acetylcysteine—Nausea—Timolol—glaucoma	0.000335	0.000634	CcSEcCtD
Acetylcysteine—CHUK—BDNF signaling pathway—BAD—glaucoma	0.000257	0.000811	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—TXNIP—glaucoma	0.000257	0.00081	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—TBK1—glaucoma	0.000252	0.000794	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—C1QB—glaucoma	0.000251	0.000792	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—BAD—glaucoma	0.00025	0.00079	CbGpPWpGaD
Acetylcysteine—IKBKB—Cardiac Hypertrophic Response—TNF—glaucoma	0.00025	0.000789	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—NGF—glaucoma	0.00025	0.000789	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000248	0.000781	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NTRK2—glaucoma	0.000247	0.000778	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—BAD—glaucoma	0.000247	0.000777	CbGpPWpGaD
Acetylcysteine—CHUK—PI-3K cascade—CDKN1B—glaucoma	0.000244	0.000769	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000242	0.000762	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—FAS—glaucoma	0.000241	0.00076	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.00024	0.000757	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—GSTM1—glaucoma	0.000239	0.000754	CbGpPWpGaD
Acetylcysteine—CHUK—PI3K/AKT activation—CDKN1B—glaucoma	0.000238	0.000751	CbGpPWpGaD
Acetylcysteine—CHUK—GAB1 signalosome—CDKN1B—glaucoma	0.000236	0.000745	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—BAD—glaucoma	0.000235	0.000742	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—NGF—glaucoma	0.000234	0.000739	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—BAD—glaucoma	0.000234	0.000738	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NGFR—glaucoma	0.000233	0.000736	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—BAD—glaucoma	0.000233	0.000736	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—BAD—glaucoma	0.000233	0.000735	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—BAD—glaucoma	0.000232	0.000731	CbGpPWpGaD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—CDKN1B—glaucoma	0.000231	0.000728	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—BAD—glaucoma	0.000229	0.000721	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—C1QB—glaucoma	0.000228	0.000718	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—MMP1—glaucoma	0.000224	0.000706	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—TXN—glaucoma	0.000224	0.000706	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NTRK1—glaucoma	0.000222	0.000699	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—TNF—glaucoma	0.000222	0.000698	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00022	0.000693	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—BAD—glaucoma	0.000218	0.000688	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—BAD—glaucoma	0.000218	0.000688	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—BAD—glaucoma	0.000218	0.000688	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—BAD—glaucoma	0.000216	0.000682	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—GSTT1—glaucoma	0.000216	0.00068	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—CAV1—glaucoma	0.000215	0.000677	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—BAD—glaucoma	0.000214	0.000676	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—BAD—glaucoma	0.000213	0.000673	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NGFR—glaucoma	0.000212	0.000667	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—MTHFR—glaucoma	0.000211	0.000666	CbGpPWpGaD
Acetylcysteine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—glaucoma	0.000208	0.000655	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—BAD—glaucoma	0.000207	0.000654	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000207	0.000652	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000205	0.000647	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—FN1—glaucoma	0.000204	0.000644	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LRP12—glaucoma	0.000203	0.00064	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—TXN—glaucoma	0.000203	0.00064	CbGpPWpGaD
Acetylcysteine—CHUK—p75(NTR)-mediated signaling—TP53—glaucoma	0.000203	0.00064	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—BAD—glaucoma	0.000202	0.000637	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NTRK1—glaucoma	0.000201	0.000634	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL1A—glaucoma	0.000198	0.000625	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—BAD—glaucoma	0.000198	0.000624	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—APOE—glaucoma	0.000197	0.00062	CbGpPWpGaD
Acetylcysteine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.000197	0.00062	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TNF—glaucoma	0.000197	0.00062	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTSA—glaucoma	0.000196	0.000618	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—TP53—glaucoma	0.000195	0.000616	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—CAV1—glaucoma	0.000195	0.000614	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000193	0.000609	CbGpPWpGaD
Acetylcysteine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—glaucoma	0.000188	0.000594	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FGFR1OP—glaucoma	0.000187	0.000589	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HEYL—glaucoma	0.000187	0.000589	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LRP12—glaucoma	0.000184	0.00058	CbGpPWpGaD
Acetylcysteine—IKBKB—p75(NTR)-mediated signaling—TP53—glaucoma	0.000184	0.00058	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—BAD—glaucoma	0.000183	0.000577	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—TNF—glaucoma	0.000183	0.000576	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000182	0.000575	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NGF—glaucoma	0.00018	0.000568	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL1A—glaucoma	0.00018	0.000567	CbGpPWpGaD
Acetylcysteine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.000178	0.000562	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—TNF—glaucoma	0.000178	0.000562	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTSA—glaucoma	0.000178	0.00056	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—TNF—glaucoma	0.000177	0.000559	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000177	0.000558	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—CDKN1B—glaucoma	0.000174	0.00055	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TP53—glaucoma	0.000173	0.000547	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—ABCA1—glaucoma	0.000172	0.000542	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—CYP1B1—glaucoma	0.000172	0.000542	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—CDKN1B—glaucoma	0.000172	0.000541	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—MMP2—glaucoma	0.000171	0.000538	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—MMP9—glaucoma	0.000169	0.000532	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.000168	0.000531	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—MMP2—glaucoma	0.000166	0.000525	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—TNF—glaucoma	0.000166	0.000523	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TXNIP—glaucoma	0.000165	0.00052	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—CDKN1B—glaucoma	0.000164	0.000517	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NGF—glaucoma	0.000163	0.000515	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—CDKN1B—glaucoma	0.000163	0.000514	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—NOS3—glaucoma	0.000162	0.000512	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—CDKN1B—glaucoma	0.000162	0.000512	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TBK1—glaucoma	0.000162	0.00051	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—CDKN1B—glaucoma	0.000162	0.000509	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000161	0.000507	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	0.000159	0.000502	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—TP53—glaucoma	0.000157	0.000496	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.000153	0.000481	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—CDKN1B—glaucoma	0.000152	0.000479	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	0.000152	0.000479	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—CDKN1B—glaucoma	0.000152	0.000479	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000151	0.000476	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—CDKN1B—glaucoma	0.000151	0.000475	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TXNIP—glaucoma	0.00015	0.000472	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—CDKN1B—glaucoma	0.000149	0.000471	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—BAD—glaucoma	0.000149	0.000469	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—CDKN1B—glaucoma	0.000149	0.000469	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—TP53—glaucoma	0.000147	0.000465	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—NOS3—glaucoma	0.000147	0.000465	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TBK1—glaucoma	0.000147	0.000463	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—C1QB—glaucoma	0.000146	0.000461	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	0.000144	0.000455	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000144	0.000452	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000143	0.000451	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—OPN4—glaucoma	0.000141	0.000444	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—CDKN1B—glaucoma	0.000141	0.000443	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	0.000138	0.000434	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—GSTM1—glaucoma	0.000137	0.000433	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—BAD—glaucoma	0.000135	0.000425	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—PTGS2—glaucoma	0.000135	0.000425	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000135	0.000424	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—C1QB—glaucoma	0.000133	0.000418	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	0.000131	0.000414	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CA1—glaucoma	0.000131	0.000414	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HEYL—glaucoma	0.000131	0.000413	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TXN—glaucoma	0.00013	0.000411	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—MMP9—glaucoma	0.000128	0.000404	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—OPN4—glaucoma	0.000128	0.000402	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—CDKN1B—glaucoma	0.000128	0.000402	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CTSA—glaucoma	0.000127	0.000401	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTGFR—glaucoma	0.000127	0.0004	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—MMP9—glaucoma	0.000125	0.000394	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MMP2—glaucoma	0.000122	0.000384	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—MTHFR—glaucoma	0.000121	0.000383	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CA2—glaucoma	0.00012	0.000378	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	0.000119	0.000376	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000119	0.000375	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MMP2—glaucoma	0.000119	0.000374	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HEYL—glaucoma	0.000119	0.000374	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TXN—glaucoma	0.000118	0.000373	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000117	0.00037	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000117	0.00037	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—VEGFA—glaucoma	0.000117	0.000369	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HDAC9—glaucoma	0.000117	0.000368	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—VEGFA—glaucoma	0.000115	0.000363	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTGFR—glaucoma	0.000115	0.000362	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—APOE—glaucoma	0.000113	0.000356	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—VEGFA—glaucoma	0.000112	0.000354	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—CAV1—glaucoma	0.000112	0.000353	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000108	0.000342	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—CDKN1B—glaucoma	0.000104	0.000326	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TNF—glaucoma	0.000102	0.000323	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000102	0.000321	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RPTOR—glaucoma	9.92e-05	0.000313	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—C3—glaucoma	9.77e-05	0.000308	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NCK2—glaucoma	9.61e-05	0.000303	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—CDKN1B—glaucoma	9.39e-05	0.000296	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—C3—glaucoma	9.39e-05	0.000296	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—BCL2L1—glaucoma	9.36e-05	0.000295	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MMP9—glaucoma	9.16e-05	0.000289	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—glaucoma	9.03e-05	0.000285	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RPTOR—glaucoma	8.99e-05	0.000283	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	8.99e-05	0.000283	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MMP9—glaucoma	8.93e-05	0.000281	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—C3—glaucoma	8.86e-05	0.000279	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—glaucoma	8.84e-05	0.000279	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NCK2—glaucoma	8.71e-05	0.000275	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—C3—glaucoma	8.51e-05	0.000268	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—BCL2L1—glaucoma	8.48e-05	0.000267	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—BAD—glaucoma	8.48e-05	0.000267	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—NOS3—glaucoma	8.47e-05	0.000267	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TXN—glaucoma	8.46e-05	0.000267	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—VEGFA—glaucoma	8.22e-05	0.000259	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HDAC9—glaucoma	8.17e-05	0.000257	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—BAD—glaucoma	8.14e-05	0.000257	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—VEGFA—glaucoma	8.02e-05	0.000253	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTGS2—glaucoma	7.74e-05	0.000244	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.72e-05	0.000243	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—BAD—glaucoma	7.69e-05	0.000242	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.65e-05	0.000241	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HDAC9—glaucoma	7.41e-05	0.000233	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—BAD—glaucoma	7.38e-05	0.000233	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—glaucoma	7.05e-05	0.000222	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—glaucoma	6.87e-05	0.000217	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTT1—glaucoma	6.56e-05	0.000207	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1A—glaucoma	6.48e-05	0.000204	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SMO—glaucoma	6.39e-05	0.000201	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN2B—glaucoma	6.27e-05	0.000198	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CDKN1B—glaucoma	5.91e-05	0.000186	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1A—glaucoma	5.87e-05	0.000185	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NTRK2—glaucoma	5.85e-05	0.000184	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SMO—glaucoma	5.79e-05	0.000183	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—C3—glaucoma	5.69e-05	0.000179	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDKN1B—glaucoma	5.67e-05	0.000179	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2L1—glaucoma	5.45e-05	0.000172	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CDKN1B—glaucoma	5.35e-05	0.000169	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NTRK2—glaucoma	5.3e-05	0.000167	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.29e-05	0.000167	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTHFR—glaucoma	5.26e-05	0.000166	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ABCA1—glaucoma	5.23e-05	0.000165	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP1B1—glaucoma	5.23e-05	0.000165	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—C3—glaucoma	5.16e-05	0.000163	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDKN1B—glaucoma	5.14e-05	0.000162	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NGFR—glaucoma	5.01e-05	0.000158	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2L1—glaucoma	4.94e-05	0.000156	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BAD—glaucoma	4.94e-05	0.000156	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOE—glaucoma	4.89e-05	0.000154	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CAV1—glaucoma	4.85e-05	0.000153	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NTRK1—glaucoma	4.76e-05	0.00015	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BAD—glaucoma	4.56e-05	0.000144	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NGFR—glaucoma	4.55e-05	0.000143	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BAD—glaucoma	4.48e-05	0.000141	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN2B—glaucoma	4.39e-05	0.000138	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NTRK1—glaucoma	4.32e-05	0.000136	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EDN1—glaucoma	4.21e-05	0.000133	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTM1—glaucoma	4.18e-05	0.000132	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN2B—glaucoma	3.98e-05	0.000126	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NGF—glaucoma	3.87e-05	0.000122	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EDN1—glaucoma	3.82e-05	0.00012	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—glaucoma	3.69e-05	0.000116	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—C3—glaucoma	3.68e-05	0.000116	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS3—glaucoma	3.67e-05	0.000116	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NGF—glaucoma	3.51e-05	0.000111	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1B—glaucoma	3.44e-05	0.000108	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOE—glaucoma	3.44e-05	0.000108	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOE—glaucoma	3.43e-05	0.000108	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CAV1—glaucoma	3.41e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CAV1—glaucoma	3.4e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—glaucoma	3.35e-05	0.000106	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—C3—glaucoma	3.34e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FN1—glaucoma	3.23e-05	0.000102	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BAD—glaucoma	3.19e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1B—glaucoma	3.18e-05	0.0001	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1B—glaucoma	3.12e-05	9.83e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOE—glaucoma	3.11e-05	9.79e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CAV1—glaucoma	3.08e-05	9.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FN1—glaucoma	2.93e-05	9.24e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BAD—glaucoma	2.9e-05	9.13e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NOS3—glaucoma	2.58e-05	8.12e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOS3—glaucoma	2.57e-05	8.09e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—glaucoma	2.36e-05	7.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOS3—glaucoma	2.33e-05	7.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1B—glaucoma	2.22e-05	7.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—glaucoma	2.06e-05	6.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1B—glaucoma	2.02e-05	6.36e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—glaucoma	1.87e-05	5.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—glaucoma	1.85e-05	5.83e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—glaucoma	1.68e-05	5.29e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—glaucoma	1.4e-05	4.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—glaucoma	1.27e-05	3.99e-05	CbGpPWpGaD
